APA (7th ed.) Citation

Jingjing Su, Yiting Fu, Zitong Cui, Zain Abidin, Jingsong Yuan, Xinmiao Zhang, . . . Chunzhen Zhao. (2024). Relatlimab: A novel drug targeting immune checkpoint LAG-3 in melanoma therapy. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Jingjing Su, Yiting Fu, Zitong Cui, Zain Abidin, Jingsong Yuan, Xinmiao Zhang, Runmin Li, and Chunzhen Zhao. Relatlimab: A Novel Drug Targeting Immune Checkpoint LAG-3 in Melanoma Therapy. Frontiers Media S.A., 2024.

MLA (9th ed.) Citation

Jingjing Su, et al. Relatlimab: A Novel Drug Targeting Immune Checkpoint LAG-3 in Melanoma Therapy. Frontiers Media S.A., 2024.